Optimizing CAR T-cell therapy to tackle solid tumors
In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite prostaglandin E2 can block T cells—the killer cells of the immune system—in the vicinity of a tumor, ...
Feb 16, 2026
0
0









